{"title":"Clinicopathological Significance and Prognostic Value of the Caveolae Constitutive Proteins Dynamin-2 and Caveolin-1 in Oral Squamous Cell Carcinoma.","authors":"Yoshiaki Kishikawa, Koroku Kato, Kyosuke Hakoda, Hayato Funaki, Hisano Kobayashi, Yutaka Kobayashi, Hiroki Miyazawa, Natsuyo Noguchi, Shuichi Kawashiri","doi":"10.1111/jop.13646","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>We investigated the clinicopathological significance of the expression of two caveolae component proteins, dynamin-2 (DNM2) and caveolin-1 (CAV1), in primary tumors of patients with oral squamous cell carcinoma (OSCC).</p><p><strong>Methods: </strong>Immunohistochemical staining for DNM2 and CAV1 was performed on resected primary tumor specimens from 80 OSCC patients, and the individual expressions and combined expression status of these proteins were analyzed in relation to clinicopathological factors and prognosis.</p><p><strong>Results: </strong>We observed that the DNM2 expression was significantly correlated with the OSCC T-classification and the stage, while CAV1 expression was significantly correlated with the mode of invasion and recurrence. Moreover, the combined DNM2/CAV1 expression status was significantly correlated with the T-classification, stage, cell differentiation, and recurrence. In terms of overall survival, the CAV1-positive patients had a significantly poorer prognosis compared to the CAV1-negative patients, and the patients who expressed neither DNM2 nor CAV1 had a significantly better prognosis than those expressing either or both proteins.</p><p><strong>Conclusion: </strong>These results suggest that in OSCC, the expression of DNM2 is involved in tumor growth and the expression of CAV1 is involved in tumor invasion, and DNM2 and/or CAV1 expression affects the progression and prognosis of OSCC. The expressions of DNM2 and CAV1 may therefore be useful markers for OSCC progression and prognosis.</p>","PeriodicalId":16588,"journal":{"name":"Journal of Oral Pathology & Medicine","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Oral Pathology & Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/jop.13646","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Background: We investigated the clinicopathological significance of the expression of two caveolae component proteins, dynamin-2 (DNM2) and caveolin-1 (CAV1), in primary tumors of patients with oral squamous cell carcinoma (OSCC).
Methods: Immunohistochemical staining for DNM2 and CAV1 was performed on resected primary tumor specimens from 80 OSCC patients, and the individual expressions and combined expression status of these proteins were analyzed in relation to clinicopathological factors and prognosis.
Results: We observed that the DNM2 expression was significantly correlated with the OSCC T-classification and the stage, while CAV1 expression was significantly correlated with the mode of invasion and recurrence. Moreover, the combined DNM2/CAV1 expression status was significantly correlated with the T-classification, stage, cell differentiation, and recurrence. In terms of overall survival, the CAV1-positive patients had a significantly poorer prognosis compared to the CAV1-negative patients, and the patients who expressed neither DNM2 nor CAV1 had a significantly better prognosis than those expressing either or both proteins.
Conclusion: These results suggest that in OSCC, the expression of DNM2 is involved in tumor growth and the expression of CAV1 is involved in tumor invasion, and DNM2 and/or CAV1 expression affects the progression and prognosis of OSCC. The expressions of DNM2 and CAV1 may therefore be useful markers for OSCC progression and prognosis.
期刊介绍:
The aim of the Journal of Oral Pathology & Medicine is to publish manuscripts of high scientific quality representing original clinical, diagnostic or experimental work in oral pathology and oral medicine. Papers advancing the science or practice of these disciplines will be welcomed, especially those which bring new knowledge and observations from the application of techniques within the spheres of light and electron microscopy, tissue and organ culture, immunology, histochemistry and immunocytochemistry, microbiology, genetics and biochemistry.